arrow
返回
N

Nilanjan Ghosh

atrium health levine cancer institute

42H指数
357论文数
1.0W被引数
收录论文 59
发表时间
Long-term survival and cause-specific mortality after event-free survival at 24 months (EFS24) in mantle cell lymphoma: an international multicohort study套细胞淋巴瘤在24个月无事件生存期(EFS24)后的长期生存和特定病因死亡率:一项国际多队列研究
err2026-09-22
err0
errOAAI
errYucai Wang; Melissa C. Larson; Umar Farooq; Sara Ekberg; Karin E. Smedby; Mikkel R. Simonsen; Peter de Nully Brown; Carsten U. Niemann; Eric J. Zhao; Alina S. Gerrie; Jeffrey M. Switchenko; David A. Bond; Veronika Bachanova; Stefan K. Barta; Brian T. Hill; Peter Martin; Alexey V. Danilov; Natalie S. Grover; Reem Karmali; Nilanjan Ghosh; Timothy S. Fenske; Brad S. Kahl; Alexandra Albertsson-Lindblad; Ingrid Glimelius; Ahmed Ludvigsen Al-Mashhadi; Thomas S. Larsen; Kami J. Maddocks; Eric Mou; Jonas Paludo; Grzegorz S. Nowakowski; Thomas M. Habermann; Matthew J. Maurer; Diego Villa; Jonathon B. Cohen; Tarec C. El-Galaly; Mats Jerkeman; James R. Cerhan
err分享
err收藏
Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B-cell non-Hodgkin lymphoma: Phase 1b dose-escalation studyGlofitamab与免疫化疗联合治疗复发/难治性B细胞非霍奇金淋巴瘤:1b期剂量递增研究
err2026-09-05
err0
errOAAI
errWilliam Townsend; Nilanjan Ghosh; Martin Hutchings; Michael Dickinson; Monica Tani; Armando Santoro; Michael Crump; Amitkumar Mehta; Reinhard Marks; Martin Weisser; Martin Barrett; Chun Wu; Derrick Kaufman; Katharina Lechner; Pauline Baumlin; Pontus Lundberg; Max S. Topp
err分享
err收藏
Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 SYMPATICO study伊布替尼联合维奈克拉用于复发/难治性套细胞淋巴瘤:SYMPATICO III期研究的最终分析
err2026-08-21
err0
errOAAI
errMichael Wang; Wojciech Jurczak; Marek Trneny; David Belada; Tomasz Wrobel; Nilanjan Ghosh; Mary-Margaret Keating; Tom van Meerten; Ruben Fernandez Alvarez; Gottfried von Keudell; Catherine Thieblemont; Frederic Peyrade; Marc Andre; Marc Hoffmann; Edith Szafer-Glusman; Jennifer Lin; James P. Dean; Jutta K. Neuenburg; Constantine S. Tam
err分享
err收藏
A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B-Cell Lymphoma一项随机II期研究:皮下注射mosunetuzumab联合polatuzumab vedotin与利妥昔单抗联合polatuzumab vedotin治疗复发或难治性大B细胞淋巴瘤患者的比较研究
err2026-07-28
err0
errOAAI
errJulio C. Chavez; Mariana Bastos-Oreiro; Catherine Diefenbach; Izidore S. Lossos; Nirav Shah; Sarit Assouline; Adam J. Olszewski; Seema Naik; Nilanjan Ghosh; Song Pham; Michael C. Wei; Connie Batlevi; Iris To; Wahib Ead; Sneha Makadia; Elicia Penuel; Jing Jing; Lihua E. Budde
err分享
err收藏
Cellular therapy in mantle cell lymphoma: recommendations from the EBMT practice harmonisation and guidelines committee
err2026-07-09
err0
errOAAI
errPeter Dreger; Gloria Iacoboni; Stephen Robinson; Ali Bazarbachi; Sascha Dietrich; Toby A. Eyre; Sairah Ahmed; Timothy S. Fenske; Nilanjan Ghosh; Mehdi Hamadani; Francesco Onida; Annalisa Ruggeri; Isabel Ortega-Sanchez; Ibrahim Yakoub-Agha; Olivier Hermine
err分享
err收藏
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton’s tyrosine kinase inhibitor therapy套细胞淋巴瘤在序贯一线 bendamustine-rituximab 和二线 Bruton 酪氨酸激酶抑制剂治疗后的预后
err2026-04-25
err0
errOAAI
errYucai Wang; Melissa C. Larson; Steven R. Hwang; Diego Villa; Laveniya Kugathasan; Anita Kumar; Ashlee Joseph; Taylor R. Brooks; Brian T. Hill; David A. Bond; Kami J. Maddocks; Alexey Danilov; Christine Argao; Jia Ruan; Imran A. Nizamuddin; Brad S. Kahl; Natalie S. Grover; Nazneen B. Khan; Georgios N. Pongas; Izidore S. Lossos; Evguenia Ouchveridze; Aung M. Tun; Firas Baidoun; Muhamad Alhaj Moustafa; Zoey I. Harris; Javier L. Munoz; Philip R. Young; Craig A. Portell; Patrick M. Reagan; Christine E. Ryan; Reid W. Merryman; Arash Velayati; I. Brian Greenwell; Drew G. Gerber; Preetesh Jain; Michael L. Wang; Sabarish R. Ayyappan; Eric Mou; Lauren G. Banaszak; Priyanka A. Pophali; Anthony C. Stack; Marcus R. Messmer; Mayur S. Narkhede; Amitkumar Mehta; Tamara K. Moyo; Nilanjan Ghosh; Rahul S. Bhansali; Stefan K. Barta; Manali K. Kamdar; Jacob Anna; Alexander V. Stanisic; Reem Karmali; Matthew J. Maurer; James R. Cerhan; Jonathon B. Cohen; Peter Martin
err分享
err收藏
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamabBrooks, T.R.; Zabor, E.C.; Bedelu, Y.; Yang, X.; Karimi, Y.H.; Nedved, A.N.; Wang, Y.; Dave, N.K.; Landsburg, D.J.; Baron, K.; et al. 接受epcoritamab或glofitamab治疗的侵袭性B细胞淋巴瘤患者的真实世界结局。Blood 2025, in press. [Google Scholar] [CrossRef]
errBlood
IF23.1
err2025-07-17
err0
PREAI
errTaylor R. Brooks; Emily C. Zabor; Yohanna B. Bedelu; Xi Yang; Yasmin H. Karimi; Adrienne N. Nedved; Yucai Wang; Nikita Dave; Daniel J. Landsburg; Kelsey Baron; Boyu Hu; Daniel C. Trotier; Priyanka A. Pophali; Jordan Miller; Natalie Grover; Catherine Reinert; Ajay Major; Tenley Schwarz; Krish Patel; Kiarash Salafian; Emily Ayers; Suchitra Sundaram; Joshua D. Brody; Marshall McKenna; Yun Kyoung Ryu Tiger; Megan Sears-Smith; Nilanjan Ghosh; Chelsea Peterson; Cyrus Khan; Sean P. Bliven; Mayur Narkhede; Alyssa Gibson; Justin Kline; Javier Munoz; Rodolfo Garza-Morales; Carrie I. Ho; Stephen D. Smith; Alex Niu; Francisco Hernandez-Ilizaliturri; Fadzai Chinyengetere; Sandeep Dave; Nayef Abdel-Razeq; Muhamad Alhaj Moustafa; Paolo F. Caimi; Brian T. Hill
err分享
err收藏
TP53 upregulation via aurora kinase inhibition overcomes primary failure to venetoclax in BCL2-rearranged lymphomas通过抑制Aurora激酶上调TP53,克服了BCL2重排淋巴瘤对Venetoclax的原发耐药。
err2025-06-01
err0
errOAAI
errMani, Rajeswaran; Benrashid, Samon; Templeton, Margaret D.; Druhan, Lawrence J.; Seegers, Sara L.; Chakraborty, Supriya; Teague, Sarah E.; Jaros, Scott C.; Yang, Hsih-Te; Foureau, David M.; Steuerwald, Nury M.; Pal, Dhananjaya; Ghosh, Nilanjan; Copelan, Edward A.; Durden, Donald L.; Avalos, Belinda R.; Park, Steven I.
err分享
err收藏
Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT studylisocabtagene maraleucel用于不适合HSCT的R/R LBCL患者的治疗:PILOT研究2期最终结果
err2025-05-05
err0
errOAAI
errAlison Sehgal; Daanish Hoda; Peter A. Riedell; Nilanjan Ghosh; Mehdi Hamadani; Gerhard C. Hildebrandt; John E. Godwin; Patrick M. Reagan; Nina D. Wagner-Johnston; James Essell; Rajneesh Nath; Scott R. Solomon; Rebecca Champion; Edward Licitra; Suzanne Fanning; Neel K. Gupta; Victor A. Chow; Brenda Yuan; Zhi Yang; Ken Ogasawara; Jerill Thorpe; Leo I. Gordon
err分享
err收藏
Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study布鲁顿酪氨酸激酶抑制剂治疗慢性淋巴细胞白血病后基于维尼托克的治疗效果: 一项国际真实世界研究
err2024-12-19
err0
errOAAI
errGhosh, Nilanjan; Eyre, Toby A.; Brown, Jennifer R.; Lamanna, Nicole; Manzoor, Beenish S.; Coombs, Catherine C.; Tuncer, Hande H.; Ujjani, Chaitra; Leslie, Lori A.; Roeker, Lindsey E.; Davids, Matthew S.; Rhodes, Joanna M.; Skarbnik, Alan P.; Sinai, Wendy; Fleury, Isabelle; Hill, Brian T.; Martinez-Calle, Nicolas; Barr, Paul M.; Jawaid, Dureshahwar; Emechebe, Nnadozie; Pearson, Laurie; Lansigan, Frederick; Choi, Yun; Jensen, Christopher E.; Fakhri, Bita; Stephens, Deborah M.; Marx, Steven E.; Schuster, Stephen J.; Coyle, Michael; Pivneva, Irina; Watson, Talissa; Guerin, Annie; Shadman, Mazyar
err分享
err收藏
Editorial: Transplantation and cellular therapy in lymphomas and plasma cell disorders
err2024-12-10
err0
errOAAI
errUsmani, Saad Z.; Ghosh, Nilanjan; Voorhees, Peter; Copelan, Edward
err分享
err收藏
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation
err2024-12-01
err0
PREAI
errGrunwald, Michael R.; Sha, Wei; He, Jiaxian; Sanikommu, Srinivasa; Gerber, Jonathan M.; Ai, Jing; Knight, Thomas G.; Fasan, Omotayo; Boseman, Victoria; Kaizen, Whitney; Chojecki, Aleksander; Ragon, Brittany K.; Symanowski, James; Avalos, Belinda; Copelan, Edward; Ghosh, Nilanjan
err分享
err收藏
Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma
err2024-11-15
err0
errOAAI
errMaakaron, Joseph E.; Asch, Adam; Popplewell, Leslie; Collins, Graham P.; Flinn, Ian W.; Ghosh, Nilanjan; Keane, Colm; Ku, Matthew; Mehta, Amitkumar; Roschewski, Mark; Hacohen-Kleiman, Gal; Huo, Yanan; Zhang, Yi; Renard, Camille; Smith, Sonali M.; Advani, Ranjana
err分享
err收藏
Real-World Outcomes with Bispecific T-Cell Engagers (REALBiTE) for Relapsed or Refractory Large B-Cell Lymphoma: A Multi-Center, Retrospective Cohort Study真实世界中使用双特异性T细胞衔接器(REALBiTE)治疗复发或难治性大B细胞淋巴瘤的结局:一项多中心、回顾性队列研究
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errBrooks, Taylor R.; Zabor, Emily C.; Bedelu, Yohana B.; Dave, Nikita; Landsburg, Daniel J.; Nedved, Adrienne N.; Wang, Yucai; Reinert, Catherine; Major, Ajay; Sears-Smith, Megan; Ghosh, Nilanjan; Salafian, Kiarash; Ayers, Emily; Miller, Jordan; Grover, Natalie; Peterson, Chelsea; Khan, Cyrus; Bliven, Sean Patrick; Narkhede, Mayur S.; Ho, Carrie, I; Smith, Stephen D.; Gibson, Alyssa; Kline, Justin; Sundaram, Suchitra; Brody, Joshua; Baron, Kelsey; Hu, Boyu; Trotier, Daniel; Pophali, Priyanka A.; Yang, Xi; Karimi, Yasmin H.; Mckenna, Marshall; Tiger, Yun Kyoung; Niu, Alex; Hernandez-Ilizaliturri, Francisco; Morales, Rodolfo Garza; Munoz, Javier; Chinyengetere, Fadzai; Dave, Sandeep; Abdel-Razeq, Nayef; Moustafa, Muhamad Alhaj; Caimi, Paolo F.; Hill, Brian T.
err分享
err收藏
Clonal Hematopoiesis of Indeterminate Potential Is Associated with Decreased Inflammatory Toxicity and Increased Late Cytopenia in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma Treated with Chimeric Antigen Receptor T-Cell Therapy具有不确定潜力的克隆性造血与接受嵌合抗原受体T细胞疗法治疗的多发性骨髓瘤和非霍奇金淋巴瘤患者中炎症毒性的降低和晚期血细胞减少的增加相关。
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errRagon, Brittany Knick; Bhutani, Manisha; Paul, Barry; Pang, Yifan; Varga, Cindy; Sanikommu, Srinivasa Reddy; Hu, Bei; Jacobs, Ryan; Moyo, Tamara K.; Atrash, Shebli; Ferreri, Christopher J.; Park, Steven I.; Foureau, David M.; Ghosh, Nilanjan; Voorhees, Peter M.; Bell, Ariel; Holmes-Snowden, Phillip; Better, Olga; Steuerwald, Nury M.; Sha, Wei; Druhan, Lawrence J.; Grunwald, Michael R.
err分享
err收藏
Representation of Minorities in Therapeutic Clinical Trials- a 15-Year Review of Lymphoma Cooperative Group Studies (Alliance A152123)少数民族在治疗性临床试验中的代表性——淋巴瘤协作组研究15年回顾 (Alliance A152123)
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errAlencar, Alvaro J.; Geyer, Susan M.; Paskett, Electra; Pederson, Levi D.; Dockter, Travis; Ghosh, Nilanjan; Adekola, Kehinde; Unger, Joseph M.; Jegede, Opeyemi; Friedberg, Jonathan W.; Kahl, Brad S.; Dinner, Shira N.; Bartlett, Nancy L.; Blum, Kristie A.; Leonard, John P.
err分享
err收藏
Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma
err2024-11-01
err1
PREAI
errHu, Bei; Vaidya, Rakhee; Ahmed, Ferdous; Ehsan, Hamid; Moyo, Tamara K.; Jacobs, Ryan W.; Pang, Yifan; Park, Steven; Wallander, Michelle L.; Shroff, Vishal; Boseman, Victoria; Beam, Travis; Elder, Jennifer; Yountz, Melissa; Jennings, Rebecca; Howard, Dianna S.; Avalos, Belinda; Copelan, Edward A.; Mesa, Ruben; Ghosh, Nilanjan
err分享
err收藏
Comparative efficacy of lisocabtagene maraleucel in the PILOT study versus second-line chemotherapy regimens in the real world
err2024-10-31
err0
errOAAI
errGhosh, Nilanjan; Sehgal, Alison; Liu, Fei Fei; Kostic, Ana; Crotta, Alessandro; De Benedetti, Marc; Faccone, Jillian; Peng, Lily; Gordon, Leo I.
err分享
err收藏